We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Lack of Testing, Data Integrity Means 483 for OTC Drugmaker
Lack of Testing, Data Integrity Means 483 for OTC Drugmaker
OTC drugmaker P&L Development received a Form 483 after investigators found the company didn’t test certain products for yeast and mold before release and for poor data integrity.